Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

CNY 3.6

(-1.37%)

Operating Income Summary of Harbin Pharmaceutical Group Co., Ltd.

  • Harbin Pharmaceutical Group Co., Ltd.'s latest annual operating income in 2023 was 659.62 Million CNY , down -11.74% from previous year.
  • Harbin Pharmaceutical Group Co., Ltd.'s latest quarterly operating income in 2024 Q3 was 245.59 Million CNY , up 15.11% from previous quarter.
  • Harbin Pharmaceutical Group Co., Ltd. reported an annual operating income of 695.8 Million CNY in 2022, up 8.31% from previous year.
  • Harbin Pharmaceutical Group Co., Ltd. reported an annual operating income of 642.41 Million CNY in 2021, up 211.2% from previous year.
  • Harbin Pharmaceutical Group Co., Ltd. reported a quarterly operating income of 213.34 Million CNY for 2024 Q2, down -12.97% from previous quarter.
  • Harbin Pharmaceutical Group Co., Ltd. reported a quarterly operating income of 245.59 Million CNY for 2024 Q3, up 15.11% from previous quarter.

Annual Operating Income Chart of Harbin Pharmaceutical Group Co., Ltd. (2023 - 1993)

Historical Annual Operating Income of Harbin Pharmaceutical Group Co., Ltd. (2023 - 1993)

Year Operating Income Operating Income Growth
2023 659.62 Million CNY -11.74%
2022 695.8 Million CNY 8.31%
2021 642.41 Million CNY 211.2%
2020 -577.69 Million CNY -195.83%
2019 602.83 Million CNY 14.31%
2018 527.37 Million CNY -19.6%
2017 655.9 Million CNY -32.12%
2016 966.34 Million CNY 30.36%
2015 741.3 Million CNY 117.97%
2014 340.1 Million CNY 42.91%
2013 237.97 Million CNY -73.84%
2012 909.74 Million CNY 33.36%
2011 682.18 Million CNY -47.15%
2010 1.29 Billion CNY 19.12%
2009 1.08 Billion CNY 11.34%
2008 973.26 Million CNY 57.85%
2007 616.57 Million CNY -10.56%
2006 689.4 Million CNY 2.84%
2005 670.34 Million CNY 88.22%
2004 356.15 Million CNY -24.59%
2003 472.27 Million CNY 13.0%
2002 417.93 Million CNY 4.55%
2001 399.72 Million CNY 19.71%
2000 333.91 Million CNY 54.82%
1999 215.67 Million CNY 40.06%
1998 153.98 Million CNY 9.85%
1997 140.18 Million CNY 7.22%
1996 130.74 Million CNY -0.21%
1995 131.02 Million CNY 12.41%
1994 116.55 Million CNY -27.7%
1993 161.2 Million CNY 0.0%

Peer Operating Income Comparison of Harbin Pharmaceutical Group Co., Ltd.

Name Operating Income Operating Income Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 79.754%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY -191.439%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY -137.988%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 51.594%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 43.771%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 46.279%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 39.868%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY 542.762%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 81.189%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY -2893.056%
Shanghai Haoyuan Chemexpress Co., Ltd. 128.32 Million CNY -414.016%
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY -63.774%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY -16.999%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 43.898%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY 1544.15%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY -73.514%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY -60.165%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 80.865%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY 39016.972%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY -289.375%
KPC Pharmaceuticals, Inc. 568.49 Million CNY -16.031%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY -0.506%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY -164.789%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY -3418.404%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY -441.672%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY -353.314%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY 587.76%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 87.119%
China National Medicines Corporation Ltd. 2.94 Billion CNY 77.597%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY -579.528%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY -579.402%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY -14.946%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 78.612%
North China Pharmaceutical Company Ltd. 540.51 Million CNY -22.037%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 56.461%
CanSino Biologics Inc. -1.93 Billion CNY 134.064%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY -637.486%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY -39.385%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY -713.342%
Dali Pharmaceuticalco.,Ltd -17.03 Million CNY 3972.145%
Tibet Weixinkang Medicine Co., Ltd. 174.96 Million CNY -277.01%
Changchun BCHT Biotechnology Co. 559.29 Million CNY -17.94%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY 2679.175%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 26.225%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY -22.921%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY -11.315%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY -279.295%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY -178.19%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 80.057%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY -235.782%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY -397.138%
Guobang Pharma Ltd. 702.26 Million CNY 6.071%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY 1167.317%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY -51.285%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY -374.777%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY -661.114%
Henan Taloph Pharmaceutical Stock Co.,Ltd 44.16 Million CNY -1393.506%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY -42.796%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY 298.738%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY -239.733%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 39.015%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY -237.487%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 26.634%
Sichuan Huiyu Pharmaceutical Co., Ltd. 124.36 Million CNY -430.383%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY -277.423%